Pharmaceutical giant Novo Nordisk has announced plans to significantly slash the wholesale acquisition cost (WAC) in the United States for... Read more
Tag: #Global Trends
Discovery of antibiotic-resistant genes in 5,000-year-old microorganisms from Romanian ice cave
A recent study published in the journal Frontiers in Microbiology has identified a bacterial strain named Psychrobacter SC65A.3 within the... Read more
Merck and Mayo Clinic join forces to accelerate drug discovery via AI
Merck and the Mayo Clinic have announced a strategic R&D agreement to integrate artificial intelligence, advanced analytics, and multimodal clinical... Read more
Novartis and Unnatural Products join forces on AI-driven macrocycle therapeutics
Novartis has entered a multi-billion dollar research collaboration and licensing agreement with Unnatural Products Inc. (UNP) to target historically "undruggable"... Read more
Zifo and Maze Therapeutics partner to streamline biobank data via AI
Zifo and Maze Therapeutics have launched a collaboration to develop scalable solutions for managing vast and fragmented biobank datasets. By... Read more
Ibex Medical Analytics announces new CEO and biopharma expansion
Ibex Medical Analytics, a leader in AI-powered pathology, has announced a strategic leadership transition alongside the expansion of its life... Read more
U.S. boosts domestic supply chain for antiviral drug precursors with $15M award
The U.S. Department of Health and Human Services (HHS) has expanded its partnership with biotech firm Manus, providing an additional... Read more
Pluri Biotech expands IP portfolio with Chinese patent for cell technology
Pluri Biotech has secured a patent from the China National Intellectual Property Administration (CNIPA) for its proprietary 3D immune cell... Read more
Eli Lilly secures licensing deal with CSL for IL-6 targeting antibody
Eli Lilly has entered into a $100 million licensing agreement with CSL Ltd. for clazakizumab, a monoclonal antibody designed to... Read more









